biote Corp. revenue by segment BTMD

Annual Quarterly

biote Corp. splits its revenue into 6 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Pellet Procedures Product Revenue at $30.3 million, 69% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	184	44	45	46	48	49	49	50	51
Pellet Procedures Product Revenue	127 -12.6% share 69.4%	30 -13.9% share 68.5%	31 -13.2% share 69.6%	32 -13.0% share 68.6%	34 -10.4% share 70.8%	35 share 72.0%	36 share 73.6%	37 share 73.4%	38 share 73.8%
Dietary Supplements	45 +12.0% share 24.7%	11 +5.7% share 25.7%	11 +19.1% share 24.6%	12 +16.0% share 25.2%	11 +8.4% share 23.3%	11 share 22.0%	9 share 18.9%	10 share 20.2%	10 share 20.1%
Other Service Revenue	—	—	1 -55.7% share 1.3%	—	0 share 0.9%	1 share 1.1%	1 share 2.7%	—	—
Shipping Fees And Other Product Revenue	—	—	—	—	—	0 share 1.0%	1 share 1.1%	1 share 1.0%	0 share 0.9%
Contract Term Services Revenue	1 -0.2% share 0.7%	0 -8.0% share 0.7%	0 -0.9% share 0.7%	0 -3.6% share 0.7%	0 +13.2% share 0.7%	0 share 0.7%	0 share 0.7%	0 share 0.7%	0 share 0.6%
Training Service Revenue	1 -55.9% share 0.4%	0 -59.8% share 0.3%	0 -60.1% share 0.3%	0 -38.9% share 0.4%	0 -60.4% share 0.5%	0 share 0.7%	0 share 0.7%	0 share 0.6%	1 share 1.1%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: BTMD (Nasdaq)
Fiscal year ends: December 31
Headquarters: Irving, TX
SEC filer status: , Emerging growth company
SEC CIK: 1819253
Former names: Haymaker Acquisition Corp. III (until May 25, 2022)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.